- Country: Brazil
- Summary: Potential Acquisition of Non -Standard Drugs Belonging to Groups: 0936 - Registered Medicines of Specific Purchase; 09.N.03.A - Antiepileptics; and 09.A.10.A - Insulin and Analogs, a ...
- BRT Ref No: 117093870
- Deadline: 14 Apr 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 90086/2025
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Object: Electronic Auction - Potential acquisition of non -standard drugs belonging to groups: 0936 - registered medicines of specific purchase; 09.n.03.A - Antiepileptics; and 09.a.10.A - Insulin and analogs, in order to meet the judicial determinations to the detriment of the Secretariat ofHealth State of the Federal District (SES/DF), according to specifications and quantities contained in Annex I of the Notice.
UASG Code: 926119
Notice from: 01/04/2025 from 08:00 to 12:00 and from 13:00 to 17:00
Proposal Delivery: From 01/04/2025 to 08:00
Cabazitaxel, concentration40 mg/ml, pharmaceutical form injectable solution
Quantity: 36
clonazepam, dosage 2 mg
quantity: 1080
insulin, type of fast action, concentration 100 IU/ml, pharmaceutical form injectable solution, additional with application system
quantity: 72
cyclosporine, concentration 0.5 mg/ml, formPharmaceutical Emulsion Ophthalmic
Quantity: 4320
Insulin, Aspart Origin, concentration 100 UI/ml, pharmaceutical form injectable solution, additional characteristic with applicator
Quantity: 396
Natalizumab, concentration 20 mg/ml, pharmaceutical form injectable solution
Quantity
Natalizumab,Concentration 20 mg/ml, pharmaceutical form injectable solution
Quantity: 135
nintedanib, composition sillet, concentration 100 mg
quantity: 4860
nintedanib, composition silet, concentration 100 mg
quantity: 1620
lanreotida acetate, concentration 180 mg/ml, pharmaceutical form solutionInjectable, additional characteristics prolonged release
Quantity: 27
lanreotide acetate, concentration 180 mg/ml, pharmaceutical form injectable solution, additional characteristics prolonged release
Quantity:9 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPotential Acquisition of Non -Standard Drugs Belonging to Groups: 0936 - Registered Medicines of Specific Purchase; 09.N.03.A - Antiepileptics; and 09.A.10.A - Insulin and Analogs, a ... - Brazil Tender
The FEDERAL DISTRICT GOVERNMENT - GDF, a Government sector organization in Brazil, has announced a new tender for Potential Acquisition of Non -Standard Drugs Belonging to Groups: 0936 - Registered Medicines of Specific Purchase; 09.N.03.A - Antiepileptics; and 09.A.10.A - Insulin and Analogs, a .... This tender is published on BrazilTenders under BRT Ref No: 117093870 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-04-14.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
